Estrogen metabolites on your DUTCH report: useful context, not a crystal ball

From estradiol to metabolites

Estradiol, the main estrogen before menopause, and estrone, the main estrogen afterward, do not stay in circulation forever. MedlinePlus notes that estrone is made by body fat and the adrenal glands as well as the ovaries and is the only estrogen women keep producing after menopause. Both are processed mainly by the liver.

In the first phase, enzymes add a hydroxyl group at one of three positions, creating 2-hydroxy, 4-hydroxy or 16-hydroxy estrogens. In the next phase, some of these are methylated or attached to other molecules so they can be excreted in urine and bile. The DUTCH Test measures several of these products in urine.

What each pathway is said to mean

• 2-OH estrogens: weakly estrogenic, often described as the 'favorable' route
• 4-OH estrogens: can form reactive compounds in lab studies, so this route draws the most concern
• 16-OH estrogens: more strongly estrogenic and linked in some studies to tissue growth
• Methylation markers: show how much of the 2-OH and 4-OH forms are being methylated, a step that involves the COMT enzyme

What the evidence supports

These ideas come from laboratory research and from studies comparing groups of people, some of which found associations between metabolite ratios and breast cancer and others that did not. Research is ongoing, but there is no validated way to use a urine metabolite ratio to predict an individual's cancer risk or to decide on treatment.

Reference ranges for urine metabolites are less established than for routine blood tests, and the DUTCH Test is a laboratory developed test that the FDA has not reviewed. The Menopause Society also notes that hormone levels fluctuate day to day, which applies to their metabolites too.

What it does not replace

Breast cancer screening is done with mammography. The U.S. Preventive Services Task Force recommends a mammogram every two years for women aged 40 to 74. A metabolite pattern, favorable or not, should never change your screening schedule.

Your real risk is shaped by factors such as age, family history, genetics, breast density, alcohol, weight after menopause and previous chest radiation. If you are worried about your risk, a formal risk assessment and genetic counseling where appropriate are the right tools.

How your clinician may use it

In practice, metabolite patterns are best treated as background detail that may support conversations you would have anyway. For example, a pattern skewed toward 4-OH estrogens with low methylation might prompt a review of alcohol intake, body weight, physical activity and diet, all of which matter for health regardless of the test.

Results may also be relevant when your clinician is choosing or adjusting hormone therapy, alongside your symptoms and history. They are not used to decide whether hormone therapy is safe for you; that is an individualized discussion of risks such as clots, stroke and breast cancer, with progesterone for endometrial protection if you have a uterus.

Questions to bring to your results visit

A metabolite report can feel overwhelming, with dials and color bands for each pathway. A few focused questions help turn it into something useful.

• Do any of these results change what you would recommend for me?
• Which results might be explained by my medicines, supplements or the timing of my collection?
• Is anything here a reason to change my screening schedule? (Usually the answer is no.)
• Which everyday changes, such as alcohol, weight or activity, would matter most for me?
• Do I need to repeat this test, and what would a repeat tell us?
• Are there blood tests or a risk assessment that would be more informative for my concern?

Be cautious with supplement protocols

Reports and websites sometimes suggest supplements such as DIM, sulforaphane or calcium D-glucarate to 'fix' metabolite ratios. Evidence that changing these ratios improves health outcomes is lacking, and supplement quality varies. Discuss any supplement with your clinician before starting, especially if you take hormone therapy or other medicines.

About the test

The DUTCH Test uses dried urine samples you collect at home and send to a CLIA-certified laboratory. Your clinician orders it, explains how to collect, and reviews your report with your history and blood work. It costs $449 one-time with no membership fee, and your price is confirmed at the eligibility review.